Netherlands· NL-2295ed1f33d5
OctaplasLG 45-70 mg/ml poeder en oplosmiddel voor oplossing voor infusie
A blood substitutes and plasma protein fractions product containing plasma, humaan, registered in Netherlands by Octapharma GmbH. The same ATC class is registered in 7 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Plasma, humaan is registered in 7 of 19 countries.
Countries holding a registration under ATC B05AA (blood substitutes and plasma protein fractions), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 4 of them publish a price we can compare per daily dose
Plasma, humaan · ATC B05AA
7 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- PLASMA, HUMAAN
- Manufacturer
- Octapharma GmbH
- Country
- Netherlands (NL)
- ATC code
- B05AA
- ATC class
- Blood substitutes and plasma protein fractions
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id129477
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05AA
Blood substitutes and plasma protein fractions, as other registers publish it.
- PolandGeloplasmaFresenius Kabi Polska Sp. z o.o.
- IrelandGeloplasma Solution for Infusion (Polyolefine/Freeflex Bag)Fresenius Kabi Deutschland GmbH
- IrelandGeloplasma, Solution for InfusionFresenius Kabi Deutschland GmbH
- IrelandLG-octaplas, Powder and solvent for solution for infusionOctapharma (IP)
- IrelandLG-octaplas, solution for infusionOctapharma (IP)
- CzechiaOCTAPLAS LGOctapharma (IP) SPRL, Anderlecht
- PolandoctaplasLGOctapharma (IP) SPRL
- FinlandoctaplasLGOctapharma AB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d8751e44-69ac-4003-b9da-c15297534450 GET /v1/drugs/d8751e44-69ac-4003-b9da-c15297534450?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder en oplosmiddel voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129477_smpc.pdf",
"strength": null,
"atc_label": "Blood Substitutes And Plasma Protein Fractions",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129477",
"excipients": [
"CITROENZUUR 1-WATER (E 330)",
"FOSFORZUUR (E 338)",
"GLYCINE (E 640)",
"NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
"WATER VOOR INJECTIE"
],
"substances": [
"PLASMA, HUMAAN"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129477.pdf",
"authorised_at": "2024/12/03",
"procedure_number": "SE/H/1866/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "129477",
"additional_monitoring": "N"
}See everything about plasma, humaan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.